Key Insights in Colorectal Cancer
In this Key Insights activity, Dr. Scott Kopetz and conference chair Axel Grothey discuss the key colorectal cancer-related take-home messages from the 2017 Great Debates and Updates in Gastrointestin...
Author: imedex
Added: 04/15/2017 (Source: Oncology Tube)
Source: Oncology Tube - April 15, 2017 Category: Cancer & Oncology Source Type: podcasts
Cirrhosis Paradox: Is the Risk for Clotting or for Bleeding?
Previously thought to be ' anticoagulated, ' patients with cirrhosis really might be hypercoagulable. Dr David Johnson explains why this paradox is a ' must understand ' for all who manage this condition. (Source: Medscape Gastroenterology Podcast)
Source: Medscape Gastroenterology Podcast - April 10, 2017 Category: Gastroenterology Authors: Medscape Source Type: podcasts
Preventive Care for Patients With IBD: Time for Action
IBD puts patients at risk for a variety of non-GI disorders and requires their doctors to provide comprehensive care. Dr David Johnson reviews new guidelines that make this task easier. (Source: Medscape Gastroenterology Podcast)
Source: Medscape Gastroenterology Podcast - February 24, 2017 Category: Gastroenterology Authors: Medscape Source Type: podcasts
Managing Obesity in Primary Care: When It's Time for Gastric Bypass
In the third installment of this series on managing obesity in primary care, Drs Vega and Apovian discuss the surgical approach. (Source: Medscape Family Medicine Podcast)
Source: Medscape Family Medicine Podcast - February 21, 2017 Category: Primary Care Authors: Medscape Source Type: podcasts
Managing Obesity in Primary Care: When It's Time for Gastric Bypass
In the third installment of this series on managing obesity in primary care, Drs Vega and Apovian discuss the surgical approach. (Source: Medscape Gastroenterology Podcast)
Source: Medscape Gastroenterology Podcast - February 21, 2017 Category: Gastroenterology Authors: Medscape Source Type: podcasts
How Will the Results of the RESORCE Trial Impact HCC Treatment
John L. Marshall of Lombardi Comprehensive Cancer Institute discusses how the results of the RESORCE Trial will impact treatment for HCC patients at the 2017 Gastrointestinal Cancers Symposium (ASCO G...
Author: obr
Added: 01/26/2017 (Source: Oncology Tube)
Source: Oncology Tube - January 26, 2017 Category: Cancer & Oncology Source Type: podcasts
Molecular Tests For Treatment Approach in a Newly Diagnosed CRC Patient
John L. Marshall, MD of Lombardi Comprehensive Cancer Center gives his perspective on how to choose molecular tests for treating newly diagnosed colorectal cancer patients at the 2017 Gastrointestinal...
Author: obr
Added: 01/26/2017 (Source: Oncology Tube)
Source: Oncology Tube - January 26, 2017 Category: Cancer & Oncology Source Type: podcasts
How Do You Integrate Genetic Mutations Into a Treatment Decision for CRC
John L. Marshall, MD of Lombardi Comprehensive Cancer Center gives his take on how to integrate genetic mutations, and left sided versus right sided CRC, into a treatment decision at the 2017 Gastroin...
Author: obr
Added: 01/26/2017 (Source: Oncology Tube)
Source: Oncology Tube - January 26, 2017 Category: Cancer & Oncology Source Type: podcasts
Integrating Checkpoint Inhibitors into GI Cancers
John L. Marshall MD, of Lombardi Comprehensive Cancer Center discusses how checkpoint inhibitors are being integrated into gastrointestinal cancers at the 2017 Gastrointestinal Cancers Symposium (ASC...
Author: obr
Added: 01/26/2017 (Source: Oncology Tube)
Source: Oncology Tube - January 26, 2017 Category: Cancer & Oncology Source Type: podcasts
Use of Vaccines For Immunotherapies in GI Cancer Patients
John L. Marshall of Lombardi Comprehensive Cancer Center discusses how vaccines can be used to broaden the use of immunotherapies in GI Cancer patients at the 2017 Gastrointestinal Cancers Symposium (...
Author: obr
Added: 01/26/2017 (Source: Oncology Tube)
Source: Oncology Tube - January 26, 2017 Category: Cancer & Oncology Source Type: podcasts
What To Consider When Treating a Newly Diagnosed Stage 4 Pancreatic Cancer Patient
Philip Agop Philip, MD, PhD, FRCP of Karmanos Cancer Institute gives his perspective on considerations when treating a newly diagnosed patient with stage 4 pancreatic cancer at the 2017 Gastrointestin...
Author: obr
Added: 01/26/2017 (Source: Oncology Tube)
Source: Oncology Tube - January 26, 2017 Category: Cancer & Oncology Source Type: podcasts
How to Use Both TAS-102 and Regorafenib in Metastatic CRC Patients
Philip Agop Philip, MD, PhD, FRCP of Karmanos Cancer Institute gives his perspective on how to use both TAS-102 and regorafenib for patients with metastatic colorectal cancer at the 2017 Gastrointesti...
Author: obr
Added: 01/26/2017 (Source: Oncology Tube)
Source: Oncology Tube - January 26, 2017 Category: Cancer & Oncology Source Type: podcasts
Should Resected Pancreatic Cancer Patients Be Offered Adjuvant Therapy
Philip Agop Philip, MD, PhD, FRCP of Karmanos Cancer Institute discusses whether or not resected pancreatic cancer patients should be offered adjuvant therapy at the 2017 Gastrointestinal Cancers Symp...
Author: obr
Added: 01/26/2017 (Source: Oncology Tube)
Source: Oncology Tube - January 26, 2017 Category: Cancer & Oncology Source Type: podcasts
Which Molecular Tests are Most Important for Treating CRC Patients
Philip Agop Philip, MD, PhD, FRCP of Karmanos Cancer Institute gives his take on choosing molecular tests for treatment for newly diagnosed Colorectal Cancer patients at the 2017 Gastrointestinal Canc...
Author: obr
Added: 01/26/2017 (Source: Oncology Tube)
Source: Oncology Tube - January 26, 2017 Category: Cancer & Oncology Source Type: podcasts
